Here, the study analyzed the m6A-modified genes with prognostic values in ccRCC and revealed that NUF2, CDCA3, and KIF14 were strongly associated with ccRCC progression, and could serve as biomarkers for ccRCC in combination with METTL14. The gene discussed is METTL14; the disease is nonpapillary renal cell carcinoma.